𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical outcomes after withdrawal of anti–tumor necrosis factor α therapy in patients with juvenile idiopathic arthritis: A twelve-year experience

✍ Scribed by Kevin Baszis; Jane Garbutt; Dana Toib; Jingnan Mao; Allison King; Andrew White; Anthony French


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
70 KB
Volume
63
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Genotoxicity of anti–tumor necrosis fact
✍ Erkan Demirkaya; Ismet Cok; Emre Durmaz; Onur K. Ulutas; Nuray Aktay Ayaz; Nesri 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 153 KB 👁 2 views

## Abstract ## Objective To assess the possible effects of both inflammation and the anti–tumor necrosis factor agents (anti‐TNF) on DNA damage with a specific assay, and their effects on the repair capacity of DNA. ## Methods From a group of 20 children with juvenile idiopathic arthritis (JIA),

Outcomes after switching from one anti–t
✍ Kimme L. Hyrich; Mark Lunt; Kath D. Watson; Deborah P. M. Symmons; Alan J. Silma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) who experience treatment failure with one anti–tumor necrosis factor (anti‐TNF) agent, due to either inefficacy or toxicity, are frequently switched to a second anti‐TNF agent, although the benefits of switching are unknown. The pres

Tolerance and effectiveness of anti–tumo
✍ Genevay, Stéphane ;Finckh, Axel ;Ciurea, Adrian ;Chamot, Anne-Marie ;Kyburz, Die 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 1 views

## Abstract ## Objective Limited data have been published on tolerance to and efficacy of classic or biologic disease‐modifying antirheumatic drugs in elderly patients with rheumatoid arthritis (RA). The goal of the present study was to evaluate the tolerance to and effectiveness of anti–tumor nec